Alejandro Gallego

449 total citations
28 papers, 279 citations indexed

About

Alejandro Gallego is a scholar working on Oncology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Alejandro Gallego has authored 28 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Reproductive Medicine and 9 papers in Obstetrics and Gynecology. Recurrent topics in Alejandro Gallego's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Genetic factors in colorectal cancer (5 papers). Alejandro Gallego is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Genetic factors in colorectal cancer (5 papers). Alejandro Gallego collaborates with scholars based in Spain, Finland and France. Alejandro Gallego's co-authors include Andrés Redondo, Marta Mendiola, Alberto Berjón, Alicia Hernández, Victoria Heredia-Soto, David Hardisson, Laura Yébenes, Jaime Feliú, Elena Arranz and Alberto Peláez‐García and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Alejandro Gallego

24 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandro Gallego Spain 10 158 58 55 50 49 28 279
Alejandra Wernicke Argentina 10 99 0.6× 63 1.1× 24 0.4× 45 0.9× 21 0.4× 33 236
Asad Haider United States 6 65 0.4× 102 1.8× 45 0.8× 146 2.9× 20 0.4× 13 287
Luis Z. Blanco United States 11 165 1.0× 60 1.0× 74 1.3× 86 1.7× 10 0.2× 32 358
R. Biamonte Italy 5 184 1.2× 55 0.9× 104 1.9× 160 3.2× 47 1.0× 8 370
J Jueckstock Germany 9 163 1.0× 139 2.4× 61 1.1× 31 0.6× 12 0.2× 31 374
Peter Widschwendter Germany 12 151 1.0× 86 1.5× 35 0.6× 54 1.1× 8 0.2× 31 306
David Shimizu United States 11 135 0.9× 162 2.8× 123 2.2× 97 1.9× 23 0.5× 26 450
Alina Abramian Germany 11 165 1.0× 62 1.1× 46 0.8× 63 1.3× 7 0.1× 30 372
Maria De Bonis Italy 10 57 0.4× 27 0.5× 35 0.6× 57 1.1× 8 0.2× 32 320
Shashi Lele United States 8 66 0.4× 31 0.5× 31 0.6× 43 0.9× 8 0.2× 17 233

Countries citing papers authored by Alejandro Gallego

Since Specialization
Citations

This map shows the geographic impact of Alejandro Gallego's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Gallego with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Gallego more than expected).

Fields of papers citing papers by Alejandro Gallego

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Gallego. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Gallego. The network helps show where Alejandro Gallego may publish in the future.

Co-authorship network of co-authors of Alejandro Gallego

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Gallego. A scholar is included among the top collaborators of Alejandro Gallego based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Gallego. Alejandro Gallego is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gallego, Alejandro, Ainhoa Madariaga, Anna Carbó, et al.. (2025). An ambispective, real-world multi-center study of DOstarlimab in patients with Recurrent or Advanced DNA mismatch repair deficient/microsatellite instability-high endometrial cancer (GEICO 120-R/DORA study). International Journal of Gynecological Cancer. 35(7). 101903–101903.
2.
Hernández, Raquel, Ana Fernández Montés, Alejandro Gallego, et al.. (2024). Prospective study of predictors for anxiety, depression, and somatization in a sample of 1807 cancer patients. Scientific Reports. 14(1). 3188–3188. 12 indexed citations
3.
4.
Spagnolo, Emanuela, Alejandra Martínez, Josep Marí‐Alexandre, et al.. (2023). Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features. International Journal of Molecular Sciences. 24(15). 12083–12083. 1 indexed citations
5.
6.
Peña, J., D. Viñal, Alejandro Gallego, et al.. (2023). Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study. Clinical & Translational Oncology. 25(12). 3519–3526. 2 indexed citations
7.
Gallego, Alejandro, Marta Mendiola, Bárbara Hernando, et al.. (2022). Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer. International Journal of Gynecological Cancer. 32(8). 1009–1016. 10 indexed citations
8.
Ruz‐Caracuel, Ignacio, Victoria Heredia-Soto, Bulat Zagidullin, et al.. (2022). Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?. Cancers. 14(4). 912–912. 5 indexed citations
9.
Heredia-Soto, Victoria, María P. De Miguel, Patricia Ruíz, et al.. (2022). Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models. Frontiers in Oncology. 12. 862321–862321. 2 indexed citations
10.
Poveda, Andrés, Raquel López-Reig, Ana Oaknin, et al.. (2022). Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study. Cancers. 14(4). 915–915. 5 indexed citations
11.
Ruz‐Caracuel, Ignacio, Álvaro López‐Janeiro, Victoria Heredia-Soto, et al.. (2021). Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(6). 1167–1176. 36 indexed citations
12.
Mendiola, Marta, Teijo Pellinen, Alberto Berjón, et al.. (2021). Prognostic implications of tumor-infiltrating T cells in early-stage endometrial cancer. Modern Pathology. 35(2). 256–265. 17 indexed citations
13.
Gallego, Alejandro, et al.. (2021). Long-term response to olaparib in BRCA1-related ovarian cancer with brain metastases. International Journal of Gynecological Cancer. 31(9). 1292–1296. 7 indexed citations
14.
Heredia-Soto, Victoria, Yinyin Wang, Patricia Ruíz, et al.. (2021). Eribulin activity in soft tissue sarcoma monolayer and three-dimensional cell line models: could the combination with other drugs improve its antitumoral effect?. Cancer Cell International. 21(1). 646–646. 7 indexed citations
15.
Viñal, D., Virginia Martínez-Marín, Alejandro Gallego, et al.. (2020). Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas. Clinical & Translational Oncology. 22(10). 1849–1856. 20 indexed citations
16.
Gallego, Alejandro, Beatriz Martínez, Ismael Ghanem, et al.. (2020). Cancer survivors referred to a long-term survivorship outpatient service within academic medical oncology: descriptive study. Journal of Cancer Survivorship. 15(6). 811–817. 2 indexed citations
17.
Gallego, Alejandro, Marta Mendiola, Alberto Berjón, et al.. (2020). Bevacizumab in recurrent ovarian cancer: could it be particularly effective in patients with clear cell carcinoma?. Clinical & Translational Oncology. 23(3). 536–542. 5 indexed citations
18.
Ruz‐Caracuel, Ignacio, Álvaro López‐Janeiro, Laura Yébenes, et al.. (2019). Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma. Cancers. 11(12). 1845–1845. 20 indexed citations
19.
Arranz, Elena, et al.. (1999). Cutaneous malignant melanoma and sun exposure in Spain. Melanoma Research. 9(2). 199–199. 56 indexed citations
20.
Barón, Manuel González, José Ignacio Chacón, Carlos García Girón, et al.. (1991). Antiemetic Regimens in Outpatients Receiving Cisplatin and Non-Cisplatin Chemotherapy: A Randomized Trial Comparing High-Dose Metoclopramide Plus Methylprednisolone with and Without Lorazepam. Acta Oncologica. 30(5). 623–627. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandra Wernicke Breakdown of academic impact, for papers by Asad Haider Breakdown of academic impact, for papers by Luis Z. Blanco Breakdown of academic impact, for papers by R. Biamonte Breakdown of academic impact, for papers by J Jueckstock Breakdown of academic impact, for papers by Peter Widschwendter Breakdown of academic impact, for papers by David Shimizu Breakdown of academic impact, for papers by Alina Abramian Breakdown of academic impact, for papers by Maria De Bonis Breakdown of academic impact, for papers by Shashi Lele
Rankless by CCL
2026